XML 52 R41.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 27, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Share-based Compensation, Fair Value of Stock-Based Compensation Granted

The following table represents the fair value of stock-based compensation granted during the year ended 2024 (in thousands):

 

 

 

Fair Value

 

Stock options

 

$

13,522

 

RSUs

 

 

17,496

 

PSUs

 

 

14,665

 

Restricted stock

 

 

703

 

Total stock-based compensation expense

 

$

46,386

 

Schedule of Compensation Cost

The Company recorded stock-based compensation expense by award as follows (in thousands):

 

 

 

Years Ended

 

 

 

2024

 

 

2023

 

 

2022

 

Employee stock options

 

$

13,824

 

 

$

12,842

 

 

$

10,403

 

Restricted stock

 

 

512

 

 

 

548

 

 

 

686

 

RSUs

 

 

11,739

 

 

 

7,987

 

 

 

4,512

 

PSUs

 

 

568

 

 

 

1,270

 

 

 

3,525

 

Nonemployee stock options

 

 

567

 

 

 

869

 

 

 

1,245

 

Total stock-based compensation expense

 

$

27,210

 

 

$

23,516

 

 

$

20,371

 

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The Company recorded stock-based compensation expense in the following categories (in thousands):

 

 

 

Years Ended

 

 

 

2024

 

 

2023

 

 

2022

 

Cost of sales

 

$

1,192

 

 

$

716

 

 

$

501

 

General and administrative

 

 

14,122

 

 

 

12,125

 

 

 

9,402

 

Selling and marketing

 

 

4,583

 

 

 

4,083

 

 

 

4,795

 

Research and development

 

 

7,313

 

 

 

6,592

 

 

 

5,673

 

Total stock-based compensation expense, net

 

 

27,210

 

 

 

23,516

 

 

 

20,371

 

Amounts capitalized as part of inventory

 

 

1,408

 

 

 

1,672

 

 

 

1,881

 

Total stock-based compensation expense, gross

 

$

28,618

 

 

$

25,188

 

 

$

22,252

 

Schedule of Unrecognized Compensation Cost, Non-Vested Stock-Based Compensation Arrangements

As of December 27, 2024, total unrecognized compensation cost related to non-vested stock-based compensation arrangements granted under the Equity Plan were as follows (in thousands):

 

 

 

2024

 

Stock options

 

$

18,474

 

Restricted stock, RSUs and PSUs

 

 

20,512

 

Total unrecognized stock-based compensation cost

 

$

38,986

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.

 

 

Years Ended

 

 

 

2024

 

 

2023

 

 

2022

 

Expected dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

Expected volatility

 

 

59

%

 

 

60

%

 

 

54

%

Risk-free interest rate

 

 

4.17

%

 

 

3.98

%

 

 

2.09

%

Expected term (in years)

 

 

5.29

 

 

 

5.05

 

 

 

5.10

 

Schedule of Share-based Compensation, Stock Options, Activity

A summary of stock option activity under the Equity Plan for the year ended December 27, 2024 was as follows:

 

 

 

Shares
(in 000’s)

 

 

Weighted-Average Exercise Price

 

 

Weighted-Average Remaining Contractual Term (years)

 

 

Aggregate Intrinsic Value (in 000’s)

 

Outstanding at December 29, 2023

 

 

2,630

 

 

$

46.38

 

 

 

 

 

 

 

Granted

 

 

640

 

 

 

37.81

 

 

 

 

 

 

 

Exercised

 

 

(315

)

 

 

23.52

 

 

 

 

 

 

 

Forfeited or expired

 

 

(147

)

 

 

70.43

 

 

 

 

 

 

 

Outstanding at December 27, 2024

 

 

2,808

 

 

$

45.72

 

 

 

6.59

 

 

$

3,961

 

Exercisable at December 27, 2024

 

 

1,826

 

 

$

47.03

 

 

 

5.38

 

 

$

3,961

 

Share-based Compensation, Performance Shares Award Unvested Activity

A summary of unvested stock options activity under the Equity Plan for the year ended December 27, 2024 was as follows:

 

 

 

Shares
(in 000’s)

 

 

Weighted-Average Grant-Date Fair Value

 

Unvested at December 29, 2023

 

 

926

 

 

$

30.09

 

Granted

 

 

640

 

 

 

21.12

 

Forfeited or expired

 

 

(147

)

 

 

34.39

 

Vested

 

 

(437

)

 

 

29.66

 

Unvested at December 27, 2024

 

 

982

 

 

$

23.62

 

Summary of Weighted Average Grant Date Fair Value of Stock Options Granted Under The Equity Plan and Total intrinsic Value of Stock options Exercised

The weighted average grant date fair value of stock options granted under the Equity Plan and the total intrinsic value of stock options exercised were as follows:

 

 

Years Ended

 

 

 

2024

 

 

2023

 

 

2022

 

Weighted-average grant-date fair value

 

$

21.12

 

 

$

28.36

 

 

$

35.68

 

Intrinsic value of options exercised (in thousands)

 

$

4,150

 

 

$

17,041

 

 

$

25,000

 

Schedule of Share-based Compensation, Restricted Stock, RSU and PSU Activity

A summary of restricted stock, RSU and PSU activity under the Equity Plan for the year ended December 27, 2024 was as follows:

 

 

 

Restricted Stock

 

 

Restricted Stock Units

 

 

Performance Stock Units

 

 

 

Units
(in 000’s)

 

 

Weighted-Average Grant-Date Fair Value

 

 

Units
(in 000’s)

 

 

Weighted-Average Grant-Date Fair Value

 

 

Units
(in 000’s)

 

 

Weighted-Average Grant-Date Fair Value

 

Outstanding at December 29, 2023

 

 

14

 

 

$

47.61

 

 

 

401

 

 

$

55.75

 

 

 

56

 

 

$

74.80

 

Granted

 

 

17

 

 

 

39.84

 

 

 

464

 

 

 

37.72

 

 

 

390

 

 

 

37.64

 

Vested

 

 

(10

)

 

 

46.88

 

 

 

(149

)

 

 

58.56

 

 

 

(24

)

 

 

74.80

 

Forfeited

 

 

(5

)

 

 

52.67

 

 

 

(21

)

 

 

47.20

 

 

 

(16

)

 

 

52.76

 

Outstanding at December 27, 2024

 

 

16

 

 

$

40.11

 

 

 

695

 

 

$

43.33

 

 

 

406

 

 

$

39.99

 

Summary of Weighted Average Grant Date Fair Value of Restricted Stock, RSU and PSU Awards Granted Under Equity Plan and Total Fair Value of Awards Vested

The weighted average grant date fair value of restricted stock, RSU and PSU awards granted under the Equity Plan and the total fair value of awards vested were as follows:

 

 

 

Years Ended

 

 

 

2024

 

 

2023

 

 

2022

 

Weighted-average grant-date fair value

 

$

37.73

 

 

$

52.98

 

 

$

74.98

 

Fair value of awards vested (in thousands)

 

$

6,283

 

 

$

7,715

 

 

$

5,023